Skip to main content

Epistaxis

1
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 2 programs with unclassified modality

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
1
DoxycyclinePhase 4Small Molecule1 trial
Active Trials
NCT04167085Completed26Est. Jun 2021
Pfizer
PfizerNEW YORK, NY
1 program
Thrombin-JMIN/A1 trial
Active Trials
NCT00814333Terminated1Est. Aug 2011
Dianosic
DianosicFrance - Strasbourg
1 program
asymmetric balloonN/A1 trial
Active Trials
NCT03912051Completed10Est. Jul 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Angeles TherapeuticsDoxycycline
Dianosicasymmetric balloon
PfizerThrombin-JMI

Clinical Trials (3)

Total enrollment: 37 patients across 3 trials

NCT04167085Angeles TherapeuticsDoxycycline

NOrth American Study for the Treatment of Recurrent epIstaxis With DoxycycLine: The NOSTRIL Trial

Start: Dec 2017Est. completion: Jun 202126 patients
Phase 4Completed
NCT03912051Dianosicasymmetric balloon

Assessment of Performance and Safety of an Asymmetric Balloon in the Treatment of Intranasal Bleeding Managed in an Emergency Setting

Start: Mar 2019Est. completion: Jul 201910 patients
N/ACompleted
NCT00814333PfizerThrombin-JMI

Trial Comparing Outcomes With Merocel Packing or Thrombin-JMI for Anterior Epistaxis

Start: Dec 2008Est. completion: Aug 20111 patients
N/ATerminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.